all in all i think not a bad quarterly and enough to keep one interested.
jaluma, i agree potential 'new business' rhetoric promising but also all too aware such glitter has been sprinkled before.
will get excited when they land but not before.
Other sprinkles of glitter include 'plans' for new molds being well underway (but are still just plans) including an australian mold.... more glitter.
exchange rate impact an interesting one and gives merit to shifting as much range cost to indonesia as possible.
most pleasing i guess is that the seeming gap to profitability is wafer thin (noting so is the whole RAN operation). even if we get only half the book value for the property that should provide sufficient working capital for a while.
.... which then brings us back to the promise of new business. hopefully some positive announcements this calendar can mean i finally move RAN from the write-off pile.
sales, sales, sales.
gltah
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
RAN
range international limited
Add to My Watchlist
0.00%
!
0.2¢

all in all i think not a bad quarterly and enough to keep one...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.878M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 4938403 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 2070004 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 4938403 | 0.002 |
23 | 50444769 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 2070004 | 6 |
0.004 | 1155263 | 3 |
0.005 | 2454695 | 3 |
0.006 | 2185526 | 2 |
0.007 | 244444 | 1 |
Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
Featured News
RAN (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online